TrialRMD open2023

Identification of PsA phenotypes with machine learning analytics using data from two phase III clinical trials of guselkumab in a bio-naïve population of patients with PsA.

Pascal Richette et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.